Walleye Trading
VRTX icon

Walleye Trading’s Vertex Pharmaceuticals VRTX Stock Holding History

Walleye Trading’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,339
Closed -$6.22M – 4765
2025
Q4 		$6.05M Buy
+13,339
New +$5.75M 0.01% 1180
2025
Q2 		– Sell
-22,021
Closed -$10.1M – 4746
2025
Q1 		$10.7M Buy
+22,021
New +$10.3M 0.02% 687
2024
Q4 		– Sell
-42,490
Closed -$19.7M – 4707
2024
Q3 		$19.8M Buy
42,490
+4,392
+12% +$2.11M 0.04% 465
2024
Q2 		$17.9M Buy
38,098
+27,260
+252% +$11.8M 0.04% 442
2024
Q1 		$4.53M Sell
10,838
-13,044
-55% -$5.51M 0.01% 1195
2023
Q4 		$9.72M Sell
23,882
-9,359
-28% -$3.46M 0.02% 794
2023
Q3 		$11.6M Buy
33,241
+31,353
+1,661% +$11M 0.03% 609
2023
Q2 		$664K Sell
1,888
-3,152
-63% -$1.06M ﹤0.01% 2522
2023
Q1 		$1.59M Sell
5,040
-1,684
-25% -$505K ﹤0.01% 1848
2022
Q4 		$1.94M Buy
6,724
+3,084
+85% +$940K 0.01% 1709
2022
Q3 		$1.05M Sell
3,640
-11,753
-76% -$3.38M ﹤0.01% 2222
2022
Q2 		$4.34M Buy
+15,393
New +$4.12M 0.01% 1123
2022
Q1 		– Sell
-4,635
Closed -$1.1M – 5952
2021
Q4 		$1.02M Sell
4,635
-18,039
-80% -$3.51M ﹤0.01% 2224
2021
Q3 		$4.11M Buy
22,674
+8,634
+61% +$1.69M 0.01% 1046
2021
Q2 		$2.83M Buy
14,040
+7,517
+115% +$1.57M 0.01% 1209
2021
Q1 		$1.4M Sell
6,523
-10,548
-62% -$2.32M 0.01% 1638
2020
Q4 		$4.04M Buy
17,071
+15,011
+729% +$3.44M 0.02% 867
2020
Q3 		$561K Sell
2,060
-10,343
-83% -$2.85M ﹤0.01% 2151
2020
Q2 		$3.6M Sell
12,403
-6,564
-35% -$1.78M 0.02% 700
2020
Q1 		$4.51M Buy
18,967
+13,393
+240% +$3.07M 0.03% 423
2019
Q4 		$1.22M Buy
+5,574
New +$1.13M 0.01% 1623
2019
Q1 		– Sell
-2,401
Closed -$443K – 4818
2018
Q4 		$398K Sell
2,401
-2,216
-48% -$384K ﹤0.01% 2713
2018
Q3 		$890K Buy
4,617
+3,402
+280% +$606K ﹤0.01% 2217
2018
Q2 		$207K Sell
1,215
-2,519
-67% -$390K ﹤0.01% 3617
2018
Q1 		$609K Sell
3,734
-1,983
-35% -$324K ﹤0.01% 2448
2017
Q4 		$857 Buy
5,717
+2,215
+63% +$328K ﹤0.01% 2084
2017
Q3 		$532 Buy
3,502
+266
+8% +$40K ﹤0.01% 2416
2017
Q2 		$417 Buy
3,236
+701
+28% +$84.4K ﹤0.01% 2552
2017
Q1 		$277 Sell
2,535
-14,192
-85% -$1.25M ﹤0.01% 2693
2016
Q4 		$1.23M Buy
16,727
+15,018
+879% +$1.22M 0.01% 1353
2016
Q3 		$149K Buy
1,709
+239
+16% +$22.6K ﹤0.01% 3012
2016
Q2 		$126K Buy
+1,470
New +$127K ﹤0.01% 3331
2016
Q1 		– Sell
-171
Closed -$15.5K – 5887
2015
Q4 		$22K Buy
+171
New +$20.6K ﹤0.01% 4372
2015
Q3 		– Sell
-669
Closed -$85.9K – 5548
2015
Q2 		$83K Buy
+669
New +$84.3K ﹤0.01% 3164
2015
Q1 		– Sell
-5,912
Closed -$708K – 4521
2014
Q4 		$702K Buy
+5,912
New +$666K 0.01% 1297
2014
Q1 		– Sell
-14,864
Closed -$1.18M – 3964
2013
Q4 		$1.1M Buy
14,864
+8,099
+120% +$564K 0.01% 1035
2013
Q3 		$513K Sell
6,765
-1,279
-16% -$102K 0.01% 1208
2013
Q2 		$644K Buy
+8,044
New +$592K 0.01% 1108

Other funds holding VRTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Walleye Trading's VRTX Position: Q1 2026 in Review

Walleye Trading sold out of Vertex Pharmaceuticals (VRTX) in Q1 2026, closing a stake of 13,339 shares — an estimated $6.22M sold.

Walleye Trading first reported a position in VRTX in Q2 2013 and held it in 38 quarters. The position peaked at $19.8M in Q3 2024. 1,691 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Walleye Trading reported no remaining Vertex Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Walleye Trading sold 13,339 Vertex Pharmaceuticals shares in Q1 2026, an estimated $6.22M.
  • Walleye Trading first reported a position in Vertex Pharmaceuticals in Q2 2013 and held it in 38 quarters.
  • Walleye Trading's Vertex Pharmaceuticals position peaked at $19.8M in Q3 2024.
  • 1,691 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.